Sleep Duration and Sleep Disturbances as Predictors of Healthy and Chronic Disease-Free Life Expectancy Between Ages 50 and 75: A Pooled Analysis of Three Cohorts.


Journal

The journals of gerontology. Series A, Biological sciences and medical sciences
ISSN: 1758-535X
Titre abrégé: J Gerontol A Biol Sci Med Sci
Pays: United States
ID NLM: 9502837

Informations de publication

Date de publication:
16 01 2019
Historique:
received: 03 08 2017
accepted: 01 02 2018
pubmed: 8 2 2018
medline: 2 11 2019
entrez: 8 2 2018
Statut: ppublish

Résumé

The aim of this study was to examine the associations of sleep duration and sleep disturbances with healthy and chronic disease-free life expectancy (LE) between ages 50 and 75. Data were drawn from repeated waves of three occupational cohort studies in England, Finland, and Sweden (n = 55,494) and the follow-up ranged from 6 to 18 years. Self-reported sleep duration was categorized into <7, 7-8.5, and ≥9 hours and sleep disturbances into no, moderate, and severe. Health expectancy was estimated with two health indicators: healthy LE based on years in good self-rated health and chronic disease-free LE based on years without chronic diseases. Multistate life table models were used to estimate healthy and chronic disease-free LE from age 50 to 75 years for each category of sleep measures in each cohort. Fixed-effects meta-analysis was used to pool the cohort-specific results into summary estimates. Persons who slept 7-8.5 hours could expect to live 19.1 (95% CI 19.0-19.3) years in good health and 13.5 (95% CI 13.2-13.7) years without chronic diseases between ages 50 and 75. Healthy and disease-free years were 1-3 years shorter for those who slept less than 7 hours or slept 9 hours or more. Persons who did not have sleep disturbances could expect to live 20.4 (95% CI 20.3-20.6) years in good health and 14.3 (95% CI 14.1-14.5) years without chronic diseases between ages 50 and 75. Healthy and disease-free years were 6-3 years shorter for those who reported severe sleep disturbances. Sleeping 7-8.5 hours and having no sleep disturbances between ages 50 to 75 are associated with longer healthy and chronic disease-free LE.

Sections du résumé

Background
The aim of this study was to examine the associations of sleep duration and sleep disturbances with healthy and chronic disease-free life expectancy (LE) between ages 50 and 75.
Methods
Data were drawn from repeated waves of three occupational cohort studies in England, Finland, and Sweden (n = 55,494) and the follow-up ranged from 6 to 18 years. Self-reported sleep duration was categorized into <7, 7-8.5, and ≥9 hours and sleep disturbances into no, moderate, and severe. Health expectancy was estimated with two health indicators: healthy LE based on years in good self-rated health and chronic disease-free LE based on years without chronic diseases. Multistate life table models were used to estimate healthy and chronic disease-free LE from age 50 to 75 years for each category of sleep measures in each cohort. Fixed-effects meta-analysis was used to pool the cohort-specific results into summary estimates.
Results
Persons who slept 7-8.5 hours could expect to live 19.1 (95% CI 19.0-19.3) years in good health and 13.5 (95% CI 13.2-13.7) years without chronic diseases between ages 50 and 75. Healthy and disease-free years were 1-3 years shorter for those who slept less than 7 hours or slept 9 hours or more. Persons who did not have sleep disturbances could expect to live 20.4 (95% CI 20.3-20.6) years in good health and 14.3 (95% CI 14.1-14.5) years without chronic diseases between ages 50 and 75. Healthy and disease-free years were 6-3 years shorter for those who reported severe sleep disturbances.
Conclusions
Sleeping 7-8.5 hours and having no sleep disturbances between ages 50 to 75 are associated with longer healthy and chronic disease-free LE.

Identifiants

pubmed: 29415200
pii: 4837199
doi: 10.1093/gerona/gly016
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

204-210

Subventions

Organisme : Medical Research Council
ID : K013351
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K013351/1
Pays : United Kingdom

Auteurs

Sari Stenholm (S)

Department of Public Health, University of Turku and Turku University Hospital, Finland.
Stress Research Institute, Stockholm University, Sweden.
Faculty of Social Sciences (Health Sciences), University of Tampere, Finland.

Jenny Head (J)

Department of Epidemiology and Public Health, University College London, UK.

Mika Kivimäki (M)

Department of Epidemiology and Public Health, University College London, UK.
Clinicum, Faculty of Medicine, University of Helsinki, Finland.
Finnish Institute of Occupational Health, Helsinki and Turku, Finland.

Linda L Magnusson Hanson (LL)

Faculty of Social Sciences (Health Sciences), University of Tampere, Finland.

Jaana Pentti (J)

Department of Public Health, University of Turku and Turku University Hospital, Finland.
Clinicum, Faculty of Medicine, University of Helsinki, Finland.

Naja H Rod (NH)

Department of Public Health, Copenhagen University, Denmark.

Alice J Clark (AJ)

Department of Public Health, Copenhagen University, Denmark.

Tuula Oksanen (T)

Finnish Institute of Occupational Health, Helsinki and Turku, Finland.

Hugo Westerlund (H)

Faculty of Social Sciences (Health Sciences), University of Tampere, Finland.

Jussi Vahtera (J)

Department of Public Health, University of Turku and Turku University Hospital, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH